Stock
The December Producer Price Index (PPI) came in cooler than expected, as equities rose in early trading, sold off, and then rebounded. The Dow...
Hi, what are you looking for?
S&P 5850 has been the most important “line in the sand” for stocks since the pullback from the 6000 level in November 2024. With the...
The December Producer Price Index (PPI) came in cooler than expected, as equities rose in early trading, sold off, and then rebounded. The Dow...
Will small cap stocks finally take on a leadership role in 2025? In this video, Dave provides a thorough technical analysis discussion of the...
Good morning and welcome to this week’s Flight Path. We saw another strong week of blue “Go” bars for the equity index. Treasury bond prices...
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
The markets consolidated throughout the past week, which was a shortened one, with Monday, June 17th being a holiday on account of Bakri Eid....
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
The markets consolidated throughout the past week, which was a shortened one, with Monday, June 17th being a holiday on account of Bakri Eid....
Extremely heavy volume that accompanies a gap higher and a reversing candle after a lengthy uptrend is typically a sign of buyers’ exhaustion and...
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...
In this StockCharts TV video, Mary Ellen reviews the broader markets, takes a close look at NVDA and other year-to-date winners that sold off last...